Most states aren’t adequately prepared to distribute the leading coronavirus vaccine, especially to rural areas, once it is approved for public use, according to a ProPublica analysis of state plans.
Pfizer announced Monday that the coronavirus vaccine it is developing was more than 90% effective and did not produce safety concerns during its large-scale trial. But, as the vaccine approached Food and Drug Administration approval, a ProPublica investigation found that states aren’t ready to administer the delivery of the vaccine to vast swaths of their populations.
“Early, when we don’t have lots of doses, I frankly do not anticipate that vaccine will be widely available in every rural community,” Centers for Disease Control and Prevention’s V
Read More